Laurence Lieberman led his former firm’s life sciences commercial disputes group | 2d
Laurence Lieberman led his former firm’s life sciences commercial disputes group | 2d
Firm chair Alden Millard points to bolstering global M&A bench as a ‘priority’ | 6d
Thomas Kendra brings emerging markets expertise to his new firm notably through his Africa work | 1w
Jenny Davies joins as a partner in Cooley’s London life sciences partnering and licensing practice | 3w
Historic attitudes favouring globalisation are fundamentally changing. | 1yr
Editor:
Californian court finds ‘strong likelihood’ that ex-employee took trade secret information to benefit his own company | 3w
Latest lawsuits in mounting patent litigation over vaccines against the two viruses | 4w
Arrival of Tim Powell continues US firm’s European IP push | 4w
GSK’s two patents declared invalid as both attempt to launch first RSV vaccine in UK market | 1mo
Decisions from the European Patent Office and more recently the Unitary Patent Court continue to develop patent law affecting the life sciences in Europe, writes Mewburn Ellis patent lawyer Nick Sutcliffe | 1mo
Tie-up to create firm with revenues of $810m and more than 1,000 lawyers | 1mo
Novartis and Genentech had accused Korean rival of “imminent infringement” through marketing of biosimilar | 2mos
Troutman Pepper Locke to have 1,600 lawyers across 33 US and two European offices | 2mos
Veteran IP litigator Hiroshi Sheraton and M&A lawyer Luciana Griebel join in London | 2mos
The way the request was processed still raises ‘significant concerns’, says the firm | 2mos
Nickolas Bogdanovich joins after Cleary M&A partner James Langston defected to Paul Weiss in May | 2mos
Firm hires from Goodwin for fifth California office | 3mos
Alexander Klett, Christoph Mikyska and Sebastian Dexheimer move over from Reed Smith and Milbank | 3mos
PEP rises 7% to £1,076k after flatlining in FY23 | 3mos
Pan-European patent court delivers first revocation judgment a year and a month after opening | 3mos
Trio of partners join from Wilson Sonsini and boutique Hooper Lundy & Bookman as Orrick continues life sciences push | 4mos